Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

about

Limbal and corneal epithelial homeostasis.Ocular surface inflammation impairs structure and function of meibomian gland.Citrate usage in the leading causes of blindness: new possibilities for the old metabolite.

P2860

Q39234874-32200726-B9E9-4C13-82F4-0142C7232D24 Q47629269-4928CB86-4F0A-41F4-9CFC-290060F05F55 Q55322513-D9040118-F12B-48CE-8464-C942267FEDB0

P2860

Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

Item

http://www.wikidata.org/entity/Q38819339

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

@en

type

Item

label

Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

@en

prefLabel

Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

@en

P1476

Current and Upcoming Therapies for Ocular Surface Chemical Injuries

@en

P2093

Ali R Djalilian

http://www.w3.org/2001/XMLSchema#string

Alireza Baradaran-Rafii

http://www.w3.org/2001/XMLSchema#string

Ebrahim Shirzadeh

http://www.w3.org/2001/XMLSchema#string

Michael J Huvard

http://www.w3.org/2001/XMLSchema#string

Zeeshan Haq

http://www.w3.org/2001/XMLSchema#string

P2860

Amniotic membrane transplantation for acute ocular burns

Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)

Ocular chemical injuries and their management

The ocular surface chemical burns

Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations

Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Adverse effects of systemic immunosuppression in keratolimbal allograft.

[Glaucoma after extremely severe chemical and thermal eye burns. Surgical possibilities]

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.

P304

48-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JTOS.2016.09.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Medi Eslani

P577

2016-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27650263

http://www.w3.org/2001/XMLSchema#string

P932

5191942

http://www.w3.org/2001/XMLSchema#string

Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

about

P2860

P2860

Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932